Literature DB >> 21431381

4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.

Roman Schniepp, Max Wuehr, Nibal Ackl, Adrian Danek, Thomas Brandt, Michael Strupp, Klaus Jahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21431381     DOI： 10.1007/s00415-011-5987-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

Review 1.  Supraspinal sites that induce locomotion in the vertebrate central nervous system.

Authors:  S Mori; K Matsuyama; F Mori; K Nakajima
Journal:  Adv Neurol       Date:  2001

Review 2.  Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking.

Authors:  Jeffrey M Hausdorff
Journal:  Hum Mov Sci       Date:  2007-07-05       Impact factor: 2.161

3.  The Activities-specific Balance Confidence (ABC) Scale.

Authors:  L E Powell; A M Myers
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-01       Impact factor: 6.053

4.  Specific influences of cerebellar dysfunctions on gait.

Authors:  Winfried Ilg; Heidrun Golla; Peter Thier; Martin A Giese
Journal:  Brain       Date:  2007-02-07       Impact factor: 13.501

5.  Imaging human supraspinal locomotor centers in brainstem and cerebellum.

Authors:  Klaus Jahn; Angela Deutschländer; Thomas Stephan; Roger Kalla; Martin Wiesmann; Michael Strupp; Thomas Brandt
Journal:  Neuroimage       Date:  2007-10-10       Impact factor: 6.556

6.  Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.

Authors:  Matthias Löhle; Wiebke Schrempf; Martin Wolz; Heinz Reichmann; Alexander Storch
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

7.  Reference group data for the functional gait assessment.

Authors:  Martha L Walker; Alvis G Austin; Gina M Banke; Suzanne R Foxx; Lynn Gaetano; Laurie A Gardner; Jill McElhiney; Kisiah Morris; Liz Penn
Journal:  Phys Ther       Date:  2007-09-04

8.  Aminopyridines for the treatment of cerebellar and ocular motor disorders.

Authors:  Michael Strupp; Roger Kalla; Stefan Glasauer; Judith Wagner; Katharina Hüfner; Klaus Jahn; Thomas Brandt
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.

Authors:  Joy T Walter; Karina Alviña; Mary D Womack; Carolyn Chevez; Kamran Khodakhah
Journal:  Nat Neurosci       Date:  2006-02-12       Impact factor: 24.884

10.  Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.

Authors:  C Jodice; E Mantuano; L Veneziano; F Trettel; G Sabbadini; L Calandriello; A Francia; M Spadaro; F Pierelli; F Salvi; R A Ophoff; R R Frants; M Frontali
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150
View more
  14 in total

Review 1.  Recent advances in the diagnosis and treatment of balance disorders.

Authors:  Klaus Jahn; Marianne Dieterich
Journal:  J Neurol       Date:  2011-10-27       Impact factor: 4.849

Review 2.  4-aminopyridine and cerebellar gait: a retrospective case series.

Authors:  Roman Schniepp; Max Wuehr; Maximilian Neuhaeusser; Ann Kathrin Benecke; Christine Adrion; Thomas Brandt; Michael Strupp; Klaus Jahn
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

3.  Experience in a short-term trial with 4-aminopyridine in cerebellar ataxia.

Authors:  I Giordano; M Bogdanow; H Jacobi; K Jahn; M Minnerop; L Schoels; M Synofzik; J Teufel; T Klockgether
Journal:  J Neurol       Date:  2013-07-04       Impact factor: 4.849

Review 4.  Recent advances in clinical neurogenetics.

Authors:  José Berciano
Journal:  J Neurol       Date:  2012-11-16       Impact factor: 4.849

Review 5.  Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.

Authors:  Katharina Feil; Tatiana Bremova; Carolin Muth; Roman Schniepp; Julian Teufel; Michael Strupp
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

Review 6.  Current Opinions and Consensus for Studying Tremor in Animal Models.

Authors:  Sheng-Han Kuo; Elan D Louis; Phyllis L Faust; Adrian Handforth; Su-Youne Chang; Billur Avlar; Eric J Lang; Ming-Kai Pan; Lauren N Miterko; Amanda M Brown; Roy V Sillitoe; Collin J Anderson; Stefan M Pulst; Martin J Gallagher; Kyle A Lyman; Dane M Chetkovich; Lorraine N Clark; Murni Tio; Eng-King Tan; Rodger J Elble
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

7.  The interrelationship between disease severity, dynamic stability, and falls in cerebellar ataxia.

Authors:  Roman Schniepp; Cornelia Schlick; Cauchy Pradhan; Marianne Dieterich; Thomas Brandt; Klaus Jahn; Max Wuehr
Journal:  J Neurol       Date:  2016-05-09       Impact factor: 4.849

8.  Increased gait variability is associated with the history of falls in patients with cerebellar ataxia.

Authors:  Roman Schniepp; Max Wuehr; Cornelia Schlick; Sabrina Huth; Cauchy Pradhan; Marianne Dieterich; Thomas Brandt; Klaus Jahn
Journal:  J Neurol       Date:  2013-11-22       Impact factor: 4.849

9.  Consensus paper: management of degenerative cerebellar disorders.

Authors:  W Ilg; A J Bastian; S Boesch; R G Burciu; P Celnik; J Claaßen; K Feil; R Kalla; I Miyai; W Nachbauer; L Schöls; M Strupp; M Synofzik; J Teufel; D Timmann
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

Review 10.  Treatment Options in Degenerative Cerebellar Ataxia: A Systematic Review.

Authors:  Harini Sarva; Vicki Lynn Shanker
Journal:  Mov Disord Clin Pract       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.